Lakefront Biotherapeutics (GLPGF) Gross Margin Growth (3y) (2024 - 2026)
Powered by 
Analysis
Lakefront Biotherapeutics (GLPGF) Gross Margin Growth (3y) (2024 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 210.97 Bn | 196.98 Bn | 7.24 Bn | -201.00 |
| 2 | Gilead Sciences | 180.98 Bn | 177.80 Bn | 6.22 Bn | 162.00 |
| 3 | Vertex Pharmaceuticals | 132.09 Bn | 124.24 Bn | 2.84 Bn | -230.00 |
| 4 | Regeneron Pharmaceuticals | 82.56 Bn | 74.57 Bn | 3.93 Bn | -168.00 |
| 5 | Argenx Se | 61.71 Bn | 56.53 Bn | 1.37 Bn | -65.00 |
| 6 | Moderna | 54.60 Bn | 49.46 Bn | 52.00 Mn | 14,836.00 |
| 7 | Alnylam Pharmaceuticals | 34.02 Bn | 30.71 Bn | 992.69 Mn | 53.00 |
| 8 | Biogen | 31.25 Bn | 29.97 Bn | 1.96 Bn | -426.00 |
| 9 | Roivant Sciences | 29.76 Bn | 29.76 Bn | 1.16 Mn | -21.00 |
| 10 | Lakefront Biotherapeutics | 1.73 Bn | 1.73 Bn | 3.51 Mn | -6,805.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6,805.00 |
| Mar 31, 2026 | -6,795.00 |
| Dec 31, 2025 | -330,019.00 |
| Sep 30, 2025 | -1,351.00 |
| Jun 30, 2025 | -527.00 |
| Mar 31, 2025 | -1,618.00 |
| Dec 31, 2024 | -565.00 |
| Sep 30, 2024 | -1,029.00 |
| Jun 30, 2024 | -209.00 |
| Mar 31, 2024 | -405.00 |